Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 19, 2018
iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37
NASHUA, N.H. and BARCELONA, Spain, April 19, 2018 (GLOBE NEWSWIRE) -- ESTRO Booth 6800 -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative ...
April 19, 2018
VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine
CAMBRIDGE, Mass., April 19, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (“VBI”) today announced the completion of enrollment with the last patient receiving the ...
April 19, 2018
Albireo to Present Data from Two Studies on Cholestatic Liver Disease at the 51st ESPGHAN Annual Meeting
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today ...
April 19, 2018
Krystal Biotech Presents Their Skin TARgeted Delivery Platform at the World Orphan Drug Congress USA
PITTSBURGH, April 18, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., ("Krystal") (NASDAQ:KRYS), a gene therapy company developing "off-the-shelf" treatments for rare dermatological diseases, today announces ...
April 19, 2018
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa
PITTSBURGH, April 19, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (“Krystal”) (KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients ...
April 19, 2018
Paratek Pharmaceuticals, Inc. Prices $140 Million of Convertible Senior Subordinated Notes due 2024
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
April 19, 2018
Keryx Biopharmaceuticals Announces Late-breaking Ferric Citrate Abstract Accepted for Presentation at the 55th ERA-EDTA Congress
BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today ...
April 16, 2018
Albireo Reports Data on Pharmacodynamic Marker for A4250 in Children with Cholestatic Liver Disease at The International Liver Congress™ 2018
BOSTON, April 14, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced that ...
April 16, 2018
Lysogene Reports First Quarter Financial Results and Provides Business Update
CAMBRIDGE, Mass. and PARIS, April 16, 2018 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a leading biopharmaceutical company pioneering gene therapy technologies to treat central ...
April 16, 2018
Biom'up reports 2017 full-year results and provides corporate update
SAINT-PRIEST, France, April 16, 2018 (GLOBE NEWSWIRE) -- Biom'up (the "Company"), a specialist in surgical hemostasis, today announced its 2017 full-year results, as approved by ...
April 16, 2018
Galmed Pharmaceuticals to Host Post-EASL Key Opinion Leader Call on the Scientific Rationale and Clinical Development of Aramchol™ for NASH
TEL AVIV, Israel, April 16, 2018 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...
April 16, 2018
Data from BioTime’s OpRegen® and Retinal Restoration Programs to Be Presented at ARVO 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that data from the ongoing OpRegen® clinical trial ...
April 16, 2018
Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting
CHICAGO and SAN DIEGO and TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO) today announced the presentation of preclinical data demonstrating ...
April 16, 2018
Foamix Announces $16 Million Investment by OrbiMed
REHOVOT, Israel and BRIDGEWATER, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing ...
April 16, 2018
AIT Therapeutics Names Stephen J. DiPalma as Chief Financial Officer
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
April 16, 2018
VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
TEL AVIV, Israel, April 16, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT) today presented a late-breaking study demonstrating a novel bi-specific antibody that induces immune-cell ...
April 16, 2018
DelMar Pharmaceuticals Announces Multiple Presentations at Annual Meeting of the American Association for Cancer Research
VANCOUVER, British Columbia and MENLO PARK, Calif., April 16, 2018 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the ...
April 16, 2018
PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
SALT LAKE CITY, April 16, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of ...
April 12, 2018
Sensorion reports full year 2017 results
MONTPELLIER, France, April 12, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotechnology company specializing in the treatment of inner ear diseases, today announces ...
April 12, 2018
Prometic Presents New PBI-4050 Clinical Data From Ongoing Alström Syndrome Phase 2 Trial
LAVAL, QC , April 12, 2018 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) announced today positive clinical activity observed in Alström syndrome (AS) patients ...
Page 90 of 158